TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
CNTB

Connect Biopharma Holdings Ltd

Healthcare · Biotechnology

1.10$ +10.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CNTB
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– -88.8% +229.3% +1,044.2% -40.2% -26.8% -20.5% -44.6%
– -89.0% +229.4% +1,010.3% -43.4% -21.3% -20.9% -47.5%
– -89.6% +269.7% +1,030.4% -70.5% +33.7% -26.0% -51.0%
– -89.3% +240.7% +1,015.9% -43.1% -22.4% -20.8% -52.7%
– -93.2% +61.6% +18,162.0% -96.9% +51.3% +199.4% -84.7%
– – +53.4% -100.1% – – – –
– +9.0% +129.9% +944.2% – – – –
– – – – – – – –
– – – +44,007.7% -10.5% -98.0% -14.5% -15.1%
– -84.3% +255.6% -62.0% -12.1% +56.6% -64.8% +54.6%
– -41.2% +56.8% +1,918.7% -13.1% +61.9% -66.5% +60.9%
– -85.0% +65.8% +599.1% +87.9% +53.2% -46.0% +109.1%
– -5.4% +22.3% +2,104.4% -6.3% -81.5% -84.5% +474.3%
– – – – -42.2% -35.6% -9.2% -54.5%
– – – – – – – –
– – -3.4% -3.1% +5.3% +0.0% +0.3% +0.8%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?